¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"3-methoxy-4-hydroxymandelic acid test"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • leuconic acid
    ·ùÄÜ»ê
  • lichenic acid
    ÁöÀÇ»ê
  • linoleic acid
    ¸®³î·¹»ê
  • linolenic acid
    ¸®³î·»»ê
  • linolic acid
    ¸®³î»ê
  • lipoic acid
    ¸®Æ÷»ê
  • lactic acid
    Á¥»ê
  • mixed acid
    È¥ÇÕ»ê
  • maleic acid
    ¸»·¹»ê
  • malic acid
    ¸»»ê
  • mucic acid
    ¹Â½Å»ê
  • muramic acid
    ¹Â¶ó¹Í»ê
  • mycolic acid
    ¹ÌÄÝ»ê
  • malonic acid
    ¸»·Ð»ê
  • myristic acid
    ¹Ì¸®½ºÆ¾»ê
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • germ tube test
    ¹ß¾Æ°ü°Ë»ç
  • glaucoma provocative test
    ³ì³»ÀåÀ¯¹ß°Ë»ç
  • glucose insulin tolerance test
    Æ÷µµ´çÀν¶¸°°ßµõ°Ë»ç
  • glucose tolerance test
    Æ÷µµ´ç°ßµõ°Ë»ç
  • graded exercise test
    ´Ù´Ü°è¿îµ¿°Ë»ç, °è´ÜÀû¿îµ¿°Ë»ç
  • guaiac test
    ÀáÇ÷°Ë»ç
  • hearing test
    û·Â°Ë»ç
  • heat stability test
    ¿­¾ÈÁ¤¼º°Ë»ç
  • heel-knee test
    ¹ß²ÞÄ¡¹«¸­°Ë»ç, Á¾½½½ÃÇè
  • heel-knee-shin test
    ¹ß²ÞÄ¡¹«¸­Á¤°­À̰˻ç
  • heel-tap test
    ¹ß²Þġġ±â°Ë»ç
  • hemadsorption test
    Ç÷±¸ÈíÂø°Ë»ç
  • hemagglutination test
    Ç÷±¸ÀÀÁý½ÃÇè, Ç÷±¸ÀÀÁý°Ë»ç
  • hemagglutination inhibition test
    Ç÷±¸ÀÀÁý¾ïÁ¦°Ë»ç
  • hemoccult test
    ÀáÇ÷°Ë»ç
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • Moloneys test
    ¸ô·Î´Ï µðÇÁÅ׸®¾Æµ¶¼Ò½ÃÇè
  • Montenegro test
    ¸óÅ׳ױ׷Π°Ë»ç
  • Multistix test
    ¸ÖƼ½ºÆ½½º½ÃÇè
  • PB score [=phonetic balance test]
    ¸í·áµµÄ¡
  • PIAT.see Peabody Individual Achievement Test
    Çǹٵ𠰳ÀμºÃëµµ °Ë»ç
  • PPD(Purified protein derivative) test
    PPD °Ë»ç.
  • Paigen test
    ÆÄÀ̰սÃÇè
  • Paul-Bunnell test
    Æú-¹ø³Ú °Ë»ç¹ý
  • Paul-Bunnell-Davidsohn test
    Æú-¹ö³Ú-´Ùºñµå¼Õ ½ÃÇè
  • Perls iron test
    Æä¸¦Áîö½ÃÇè
  • Phenstix test
    Ææ½ºÆ½½º°Ë»ç
  • Prausnitz-Kustner test
    ÇÁ¶ó¿ì´ÏÃ÷-Äû½ºÆ®³Ê½ÃÇè.
  • Prausnitz-Kustner test
    ÇÁ¶ó¿ì½º´ÏÃ÷ Äû½ºÆ®³Ê °Ë»ç
  • Prausniz-K stner test
    ÇÁ¶ó¿ì½º´ÏÃ÷-Äû½ºÆ®³Ê½ÃÇè
  • Quellung test
    Çù¸·ÆØÃ¢½ÃÇè(úúدø³óìãËúÐ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • lipoic acid
    ¸®Æ÷»ê(¡­ß«).
  • lipoteichoic acid
    ÁöÁúŸÀÌÄÚ»ê
  • lithocholic acid
    ¸®ÅäÄÝ»ê(¡­ß«).
  • low acid food
    Àú»ê½Äǰ.
  • lysosomal acid phosphatase
    ¸®¼Ò¼Ø¼º »ê ÀλêÈ¿¼Ò(¡­àõ ß« ×òß«ý£áÈ)
  • maleic acid
    ¸»·¹»ê(¡­ß«).
  • malic acid
    ¸»»ê(¡­ß«).
  • malonic acid
    ¸»·Ð»ê(¡­ß«).
  • maximum acid output
    ÃÖ´ë»ê¹èÃâ·®
  • maximum acid output
    ÃÖ´ë»êºÐºñ·®(õÌÓÞß«ÝÂù²åÖ).
  • mesitonic acid
    ¸Þ½ÃÅæ»ê.
  • mesityluric acid
    ±×¸®Äݰú °áÇÕÇÏ¿© ¿äÁßÀ¸·Î ¹è¼³µÇ´Â ¸Þ½ÃÆ¿·».
  • messenger ribonucleic acid =m RNA
    Àü·É RNA.
  • messenger ribonucleic acid =m RNA
    Àü·É ¸®º¸ÇÙ»ê.
  • messenger ribonucleic acid= m RNA
    Àü·É¸®º¸ÇÙ»ê(îîç©¡­ú·ß«).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • monoenoic fatty acid
    ÀÏ(ìé)¿£ Áö¹æ»ê(ò·Û¸ß«)
  • monoprotic acid
    ÀϾçÀÚ»ê(ìéÕáí­ß«)
  • montanic acid
    ¸óź»ê(ß«)
  • muramic acid
    ¹Â¶ó¹Î»ê(ß«)
  • mycolic acid
    ¸¶ÀÌÄÝ»ê(ß«)
  • myristic acid
    ¹Ì¸®½ºÆ®»ê(ß«)
  • nalidixic acid
    ³¾¸®µñ»ê(ß«)
  • nervonic acid
    ³Êº»»ê(ß«)
  • neuraminic acid
    ´º¶ó¹Î»ê(ß«)
  • neutral amino acid
    Áß¼º(ñéàõ) ¾Æ¹Ì³ë»ê(ß«)
  • nicotinic acid
    ´ÏÄÚÆ¾»ê(ß«)
  • nicotinic acid amide
    ´ÏÄÚÆ¾»ê(ß«) ¾Æ¸¶À̵å
  • nitrous acid
    ¾ÆÁú»ê(ä¬òòß«)
  • nitrous acid mutant
    ¾ÆÁú»êº¯ÀÌü(ä¬òò߫ܨì¶ô÷)
  • nonionized acid
    ºñ(Þª)ÀÌ¿ÂÈ­(ûù) »ê(ß«)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 20
PFT   1) Platelet Function Test
  2) Pulmonary Function Test
PK test Prausnitz-Ku:stner test
PSP test Phenol-Sulfon-Phthalein test
RAST Radio-Allergo-Sorbent Test
  ; Specific IgE Test
RNS test Repetitive Nerve Stimulation test
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 20
IDST intradermal skin test
IVGTT Intravenous Glucose Tolerance Test
IVFTT Intravenous fat tolerance test
LAT Latex Agglutination Test
LST Leishmanin skin test
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • cold water test
    ħ¼ö¹ý
  • collateral circulation test
    ÃøºÎ ¼øÈ¯ ½ÃÇè
  • colloidal gold test
    ±³»ó±Ý °Ë»ç, ±³»ó ¿°È­±Ý ½ÃÇè
  • color blindness test chart
    »ö°¢ °Ë»çÇ¥, »ö¸Í °Ë»çÇ¥
  • color form sorting test
    »öä ÇüÅ Ã߸®±â °Ë»ç
  • Comessatti's test
    ÄÚ¸ä»çƼ ½ÃÇè
  • complement consumption test
    º¸Ã¼ ¼Òºñ ½ÃÇè
  • complement fixation inhibition test
    º¸Ã¼ °íÁ¤ ÀúÇØ ½ÃÇè
  • complement fixation test
    º¸Ã¼ °áÇÕ ½ÃÇè, º¸Ã¼ °áÇÕ °Ë»ç, º¸Ã¼ °íÁ¤ °Ë»ç
  • Congo red test
    Äá°í Àû ½ÃÇè, Äá°í ·¹µå ½ÃÇè
  • constriction test
    ¾Ð¹Ú ½ÃÇè
  • contraction stress test
    ¼öÃà ÀÚ±Ø °Ë»ç
  • controlled exercise test
    Á¶ÀýµÈ ¿îµ¿ °Ë»ç
  • coomb's antiglobulin test
    Å©¿òÁî Çױ۷κó ½ÃÇè
  • Coombs consumption test
    Äñ½º ¼Ò¸ð °Ë»ç
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
widal test <investigation> A test involving agglutination of typhoid bacilli when they are mixed with serum containing typhoid antibodies from an individual having typhoid fever, used to detect the presence of Salmonella typhi and s. Paratyphi.
Pronounced: vidal
(13 Nov 1997)
complementation-fixation test <investigation> A test for the presence of antibodies in a serum, based on whether an antigen and complement, when put together with some red blood cells, are able to destroy them. If the red blood cells are destroyed, then antibodies were not present to prevent it. If the red blood cells are not destroyed, then antibodies were present to combine with the antigen and bind the complement, making them unable to attack the red blood cells.
(09 Oct 1997)
complement-fixation test An immunological test for determining the presence of a particular antigen or antibody when one of the two is known to be present, based on the fact that complement is "fixed" in the presence of antigen and its specific antibody.
See: Bordet-Gengou phenomenon.
(05 Mar 2000)
plasmacrit test A serologic screening method used as an aid in the diagnosis of syphilis; after only a few drops of heparinised blood (obtained from a pricked finger) are collected in a special capillary tube, the capillary tube is centrifugated in order to collect plasma, which is then mixed with a 0.01-ml drop of antigen (cardiolipin previously treated with choline chloride as an anti-inhibitor, in order to avoid falsely negative results that may occur with nonheated plasma or serum). After mechanically agitating the antigen-plasma mixture for 4 min, the presence or absence of flocculation is observed. A positive result should not be regarded as conclusively diagnostic, but a negative result excludes the likelihood of syphilis.
(05 Mar 2000)
mucin clot test A test that reflects the polymerization of synovial fluid hyaluronate; a few drops of synovial fluid added to acetic acid form a clot; poor clot formation occurs in a variety of inflammatory conditions including septic arthritis, gouty arthritis, and rheumatoid arthritis.
Synonym: Ropes test.
(05 Mar 2000)
platelet aggregation test A test of the ability of platelets to adhere to each other and hence form a haemostatic plug to prevent bleeding; failure to aggregate occurs in several conditions, e.g., thrombasthenia, Von Willebrand's disease, and following administration of aspirin, phenylbutazone, and indomethacin; the test is conducted by quantitating the decrease in turbidity that occurs in platelet-rich plasma following the in vitro addition of one or several platelet-aggregating agents (e.g., ADP, epinephrine, or serotonin).
(05 Mar 2000)
Mulder's test A qualitative test for proteins; a yellow product is formed by reacting proteins with hot, concentrated nitric acid.
(05 Mar 2000)
multiple sleep latency test A test of the propensity to fall asleep, done by performing polysomnography during multiple brief opportunities to sleep.
(05 Mar 2000)
Wormley's test A test for alkaloids, by treating the solution with picric acid or a dilute iodine-potassium-iodide solution, the presence of alkaloids being shown by a colour reaction.
(05 Mar 2000)
mumps sensitivity test A skin test for sensitivity to mumps, in which inactivated mumps virus is used as antigen.
(05 Mar 2000)
mumps skin test antigen A sterile suspension of killed mumps virus in isotonic sodium chloride solution, used to determine susceptibility to mumps or to confirm previous exposure.
(05 Mar 2000)
Wurster's test A test for tyrosine; the substance is dissolved in boiling water and quinone is added; if tyrosine is present a ruby-coloured reaction takes place, the solution changing to brown after a few hours.
(05 Mar 2000)
contraction stress test A test used to evaluate foetal well-being by inducing contractions and analyzing the foetal heart rate response.
(05 Mar 2000)
coombs' test Haemagglutination test in which coombs' reagent (antiglobulin, or anti-human globulin rabbit immune serum) is added to detect incomplete (non-agglutinating, univalent, blocking) antibodies coating erythrocytes. The direct test is applied to red cells which have been coated with antibody in vivo (e.g., in haemolytic disease of newborn, autoimmune haemolytic anaemia, and transfusion reactions). The indirect test is applied to serum to detect the presence of antibody (e.g., in detection of incompatibility in cross-matching tests, detection and identification of irregular antibodies, and in detection of antibodies not identifiable by other means).
(12 Dec 1998)
point system test types A near-vision test chart in which the various test types are multiples of a point (1/72 inch), lower-case letters being one-half the designated point size; reading 4-point at 16 inches is normal, and is designated N-4.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 20
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 20
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 20
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 20
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 20
ÅëÇÕ°Ë»ö ¿Ï·á